Caladrius Biosciences Reports 2016 Second Quarter Financial Results
Aug 09, 2016 20:09 pm UTC| Business
Total Quarterly Revenues Increase 41% and Expenses Decrease 50% versus Prior Year Conference Call Begins Today at 5:00 pm Eastern Time BASKING RIDGE, N.J., Aug. 09, 2016 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS)...
Fogo de Chão, Inc. Reports Second Quarter 2016 Results
Aug 09, 2016 20:06 pm UTC| Business
DALLAS, Aug. 09, 2016 -- Fogo de Chão, Inc. (NASDAQ:FOGO) today reported financial results for its 13-week fiscal second quarter ended July 3, 2016. Key Highlights for the Second Quarter of 2016 Include: Total...
Stereotaxis Completes Niobe® System Installation at Kakogawa Hospital
Aug 09, 2016 20:06 pm UTC| Business
ST. LOUIS, Aug. 09, 2016 -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the launch of its Niobe® remote magnetic navigation system...
Calithera Biosciences Reports Second Quarter 2016 Financial Results and Recent Highlights
Aug 09, 2016 20:06 pm UTC| Business
Two novel agents that modulate tumor and immune cell metabolism in clinical developmentCalithera to host conference call today at 4:30pm ET SOUTH SAN FRANCISCO, Calif., Aug. 09, 2016 -- Calithera Biosciences, Inc....
Xcel Brands Announces Second Quarter 2016 Financial Results
Aug 09, 2016 20:06 pm UTC| Business
Company Reports Double-Digit Quarterly Revenue Growth of 44% to $9.1 Million Second Quarter 2016 GAAP Net Loss of less than ($0.1) million; Non-GAAP Net Income of $2.1 million, or Nearly Double from Second...
Lumentum Announces Fiscal Fourth Quarter and Full Year 2016 Results
Aug 09, 2016 20:06 pm UTC| Business
Fourth Fiscal Quarter Highlights Net Revenue of $241.7 million at high-end of guidanceGAAP Operating margin of 4.2%; Non-GAAP Operating margin of 11.6% exceeded high-end of guidanceGAAP diluted Net income per share of...
Lumentum Announces Fiscal Fourth Quarter and Full Year 2016 Results
Aug 09, 2016 20:06 pm UTC| Business
Fourth Fiscal Quarter Highlights Net Revenue of $241.7 million at high-end of guidanceGAAP Operating margin of 4.2%; Non-GAAP Operating margin of 11.6% exceeded high-end of guidanceGAAP diluted Net income per share of...